Browsing by Subject
Ara mostrant els elements 1-11 d 11
-
Bempegaldesleukin Plus Nivolumab in Untreated Advanced Melanoma: The Open-Label, Phase III PIVOT IO 001 Trial Results
(American Society of Clinical Oncology, 2023-10-20) -
BRAF activation by metabolic stress promotes glycolysis sensitizing NRASQ61-mutated melanomas to targeted therapy
(Nature Portfolio, 2022-11-19) -
Combined immunotherapy in melanoma patients with brain metastases: A multicenter international study
(Elsevier, 2024-01-19) -
Current Perspectives and Novel Strategies of NRAS-Mutant Melanoma
(Dove Medical Press, 2021-06-09) -
Durable Response to Vemurafenib and Cobimetinib for the Treatment of BRAF-Mutated Metastatic Melanoma in Routine Clinical Practice
(Dove Medical Press, 2021-11-27) -
Reducing MYC's transcriptional footprint unveils a good prognostic gene signature in melanoma
(Cold Spring Harbor Laboratory Press, 2023-04-01) -
SEOM clinical guideline for the management of cutaneous melanoma (2020)
(Springer, 2021-05) -
STK11 (LKB1) missense somatic mutant isoforms promote tumor growth, motility and inflammation
(Nature Research, 2020-07-09) -
Variable interplay of UV-induced DNA damage and repair at transcription factor binding sites
(Oxford University Press, 2021-01-25)